ValuentumAd

Official PayPal Seal













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Sep 5, 2012
Will Windows 8 Be Tragic for Microsoft?
Windows 8 hasn't hit the shelves yet, but skeptics are already declaring it a collossal failure.
Sep 4, 2012
ARM Warns about Weak Demand in the Second Half
ARM Holdings' CEO announced that it expects weak end-market demand in coming periods, but we don't think such a view will impact Apple.
Aug 31, 2012
Market Awaits Bernanke’s Speech
The market remains focused on Bernanke's Jackson Hole speech.
Aug 28, 2012
What Is Going on at Intel?
The chip giant has faced some pressure recently, but why?
Aug 27, 2012
Courts Dish Out a Victory to Apple
Apple wins a landmark case and could begin to block sales of Samsung devices.
Aug 23, 2012
Hewlett-Packard Is in the Midst of a Turnaround
Computing giant HP issued a poor outlook, but the company still generated substantial cash in its third quarter. We think shares are cheap, but that doesn't mean we are buying.
Aug 22, 2012
Apple Victim Dell Changes to Survive
Dell issued a dismal outlook after reporting mixed second quarter results. The firm continues to struggle, and we remain on the sidelines.
Aug 21, 2012
Best Buy on Its Way to Becoming a Value Stock
Best Buy continues to struggle, but we think it will become a value stock--just not yet.
Aug 17, 2012
Our Outlook for the Market
President of Equity Research & ETF Analysis, Brian Nelson offers insight into Valuentum's outlook for the market.
Aug 16, 2012
Hedge Fund Manager Bets Big on Health Insurers
Hedge fund manager David Einhorn established positions in several large health insurers. We like the move, but prefer the Healthcare Select Sector SPDR (XLV).


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.